119 related articles for article (PubMed ID: 10895070)
1. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Oncology; 2000 Jun; 59(1):68-74. PubMed ID: 10895070
[TBL] [Abstract][Full Text] [Related]
2. Expression of the G2-M modulators in pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Okada M; Matsuura N
Pancreatology; 2002; 2(2):138-45. PubMed ID: 12123094
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
4. Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(8):533-8. PubMed ID: 14533937
[TBL] [Abstract][Full Text] [Related]
5. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Pathol Res Pract; 2002; 198(6):397-402. PubMed ID: 12166896
[TBL] [Abstract][Full Text] [Related]
6. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications.
Jin YH; Park CK
J Korean Med Sci; 2002 Jun; 17(3):322-7. PubMed ID: 12068134
[TBL] [Abstract][Full Text] [Related]
8. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
9. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
Banerjee SK; Weston AP; Zoubine MN; Campbell DR; Cherian R
Am J Pathol; 2000 Jan; 156(1):217-25. PubMed ID: 10623670
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer.
Kim DH
Yonsei Med J; 2007 Aug; 48(4):694-700. PubMed ID: 17722244
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.
Kallakury BV; Sheehan CE; Rhee SJ; Fisher HA; Kaufman RP; Rifkin MD; Ross JS
Cancer; 1999 Apr; 85(7):1569-76. PubMed ID: 10193948
[TBL] [Abstract][Full Text] [Related]
12. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.
Dash BC; El-Deiry WS
Mol Cell Biol; 2005 Apr; 25(8):3364-87. PubMed ID: 15798220
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
15. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
16. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
Nomura N; Nomura M; Newcomb EW; Zagzag D
Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
[TBL] [Abstract][Full Text] [Related]
17. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cyclin B1 and cdc2 expression during 9-nitrocamptothecin-induced regression of DU145 prostate tumor.
Chatterjee D; Wyche JH; Pantazis P
Anticancer Res; 2000; 20(6B):4477-82. PubMed ID: 11205291
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on the expression of p34(cdc2) and cyclin B1 in pig oocytes in vitro.
Chen WY; Yang JG; Li PS
Mol Reprod Dev; 2000 May; 56(1):74-9. PubMed ID: 10737969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
